超声与MIBI SPECT/CT阴性或不确定时F18-胆碱PET/CT引导原发性甲状旁腺功能亢进手术:APACH1研究
APACH1是一项前瞻性双中心研究,纳入25例原发性甲状旁腺功能亢进且颈部超声和Tc99m-sestaMIBI SPECT/CT阴性或不确定的患者,术前行F18-胆碱PET/CT并据此引导手术。FCH PET/CT在病灶水平和患者水平的灵敏度分别为91.3%和90.5%,阳性预测值分别为87.5%和86.4%;75%的患者可避免双侧颈部探查。
要点
- 25例常规影像阴性或不确定的原发性甲状旁腺功能亢进患者中,19例(76%)FCH PET/CT评分为阳性。
- 将不确定结果归为阳性后,病灶水平和患者水平灵敏度分别为91.3%和90.5%。
- FCH PET/CT引导手术使75%的患者避免双侧颈部探查。
核心结论
- 术前FCH PET/CT在原发性甲状旁腺功能亢进且常规影像阴性或不确定的患者中,对甲状旁腺腺瘤检测具有高灵敏度和阳性预测值。
- 多数(75%)患者可避免双侧颈部探查。
研究设计与样本
- 前瞻性双中心研究(NCT02432599),共纳入25例原发性甲状旁腺功能亢进且颈部超声和Tc99m-sestaMIBI SPECT/CT阴性或不确定的患者。
- 所有患者接受FCH PET/CT,结果评分为阳性、不确定或阴性,并记录摄取灶数量及部位。
- FCH PET/CT结果引导手术方式(微创甲状旁腺切除术、双侧颈部探查,或多发/异位灶时其他术式)。
- FCH PET/CT结果与手术、病理及随访结果比较。
主要发现
- 术前平均钙为2.76±0.17 mmol/l,平均PTH为94.8±37.4 ng/l。
- 19例(76%)FCH PET/CT评分为阳性,3例(12%)不确定,3例(12%)阴性;显示21例单腺体病变,包括1例异位定位和1例多腺体(3个病灶)病变。
- 平均病灶大小为13.1±8.6 mm。
- 24例患者接受手术;FCH PET/CT引导了22例(88%)的手术,包括17例微创甲状旁腺切除术、1例因多灶行双侧颈部探查和4例其他术式;2例FCH PET/CT阴性患者行双侧颈部探查。
- 将不确定结果归为阳性后,病灶水平和患者水平灵敏度分别为91.3%(95%CI:72.0-98.9)和90.5%(95%CI:69.6-98.8),阳性预测值分别为87.5%(95%CI:67.6-97.3)和86.4%(95%CI:65.1-97.1)。
关键数值与推荐
- FCH PET/CT结果评分为阳性、不确定或阴性,记录摄取灶数量及部位。
- 将不确定结果归为阳性后,病灶水平灵敏度91.3%(95%CI:72.0-98.9),患者水平灵敏度90.5%(95%CI:69.6-98.8)。
- 病灶水平阳性预测值87.5%(95%CI:67.6-97.3),患者水平阳性预测值86.4%(95%CI:65.1-97.1)。
临床怎么用
- 在原发性甲状旁腺功能亢进且颈部超声和Tc99m-sestaMIBI SPECT/CT阴性或不确定的患者中,术前FCH PET/CT结果可引导手术方式选择。
- FCH PET/CT引导手术使75%的患者避免双侧颈部探查。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the sensitivity of F18-choline (FCH) PET/CT for parathyroid adenoma detection prior to surgery in patients with primary hyperparathyroidism and negative or inconclusive cervical ultrasound and Tc99m-sestaMIBI SPECT/CT. METHODS: We conducted a prospective bicentric study (NCT02432599). All patients underwent FCH PET/CT. The result was scored positive, inconclusive or negative. The number of uptakes and their sites were recorded. The FCH PET/CT result guided the surgical procedure (minimally invasive parathyroidectomy, bilateral cervical exploration, or other in case of multiple or ectopic foci). FCH PET/CT results were compared to the surgical and pathological findings and the follow-up. RESULTS: Twenty-five patients were included. Mean calcium and PTH levels prior to surgery were 2.76 ± 0.17 mmol/l and 94.8 ± 37.4 ng/l. Nineteen (76%) FCH PET/CTs were scored positive, 3 (12%) inconclusive and 3 (12%) negative, showing 21 cases of uniglandular disease, including 1 ectopic localization and 1 case of multiglandular (3 foci) disease. Mean lesion size was 13.1 ± 8.6 mm. Twenty-four patients underwent surgery. FCH PET/CT guided surgery in 22 (88%) patients, allowing for 17 minimally invasive parathyroidectomies, 1 bilateral cervical exploration for multifocality and 4 other surgical procedures. Two patients with negative FCH-PET/CT underwent bilateral cervical exploration. When dichotomizing the FCH PET/CT results, thereby classifying the inconclusive FCH PET/CT results as positive, the per lesion and per patient sensitivities were 91.3% (95%CI: 72.0-98.9) and 90.5% (95%CI: 69.6-98.8) and the corresponding positive predictive values were 87.5% (95%CI: 67.6-97.3) and 86.4% (95%CI: 65.1-97.1), respectively. Twenty-one (88%) patients were considered cured after surgery. Their mean calcium level after surgery was 2.36 ± 0.17 mmol/l. CONCLUSIONS: Preoperative FCH PET/CT has a high sensitivity and positive predictive value for parathyroid adenoma detection in patients with primary hyperparathyroidism and negative or inconclusive conventional imaging results. Bilateral cervical exploration could be avoided in the majority (75%) of patients.
引用
- Quak E, Blanchard D, Houdu B, et al. F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 study. Eur J Nucl Med Mol Imaging. 2017. PMID: 29270788. doi:10.1007/s00259-017-3911-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。